Neuronal histaminergic system in aging and age-related neurodegenerative disorders

Experimental Gerontology

Volumn 48, Issue 7, 2013, Pages 603-607

  Shan, Ling ^a,b   Swaab, Dick F ^b   Bao, Ai Min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Alzheimer's disease; Histamine; Histamine receptor; Histamine methyltransferase; Histidine decarboxylase; Parkinson's disease

Indexed keywords

HISTAMINE; HISTAMINE RECEPTOR; HISTIDINE DECARBOXYLASE; MELATONIN 1 RECEPTOR; PROTEIN C FOS; TYROSINE 3 MONOOXYGENASE;

AGING; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CEREBROSPINAL FLUID; CIRCADIAN RHYTHM; ENDOPLASMIC RETICULUM; ENZYME INACTIVATION; ENZYME SYNTHESIS; HOMEOSTASIS; HUMAN; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; POSTERIOR HYPOTHALAMUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPINAL CORD MOTONEURON; SUBSTANTIA NIGRA; SUPRACHIASMATIC NUCLEUS; SYNAPTIC TRANSMISSION; THALAMUS; THERMOREGULATION; TUBEROMAMILLARY NUCLEUS;

AGE FACTORS; AGING; ANIMALS; BRAIN; HISTAMINE; HISTAMINE ANTAGONISTS; HISTAMINE N-METHYLTRANSFERASE; HISTIDINE DECARBOXYLASE; HUMANS; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEURONS; RECEPTORS, HISTAMINE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84879029748     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.08.002     Document Type: Article

References (45)

1. Anichtchik O.V., Rinne J.O., Kalimo H., Panula P. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp. Neurol. 2000, 163:20-30.
2. Anichtchik O.V., Peitsaro N., Rinne J.O., Kalimo H., Panula P. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol. Dis. 2001, 8:707-716.
3. Benarroch E.E. Histamine in the CNS: multiple functions and potential neurologic implications. Neurology 2011, 75:1472-1479.
4. Braak H., Braak E., Bohl J. Staging of Alzheimer-related cortical destruction. Eur. Neurol. 1993, 33:403-408.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
6. Brioni J.D., Esbenshade T.A., Garrison T.R., Bitner S.R., Cowart M.D. Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J. Pharmacol. Exp. Ther. 2011, 336:38-46.
7. Connelly W.M., Shenton F.C., Lethbridge N., Leurs R., Waldvogel H.J., Faull R.L., Lees G., Chazot P.L. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br. J. Pharmacol. 2009, 157:55-63.
8. Dai H., Kaneko K., Kato H., Fujii S., Jing Y., Xu A., Sakurai E., Kato M., Okamura N., Kuramasu A., Yanai K. Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors. Neurosci. Res. 2007, 57:306-313.
9. Egan M., Yaari R., Liu L., Ryan M., Peng Y., Lines C., Michelson D. Pilot randomized controlled study of a histamine receptor inverse agonist in the symptomatic treatment of AD. Curr. Alzheim. Res. 2012, 9:481-490.
10. Fernandez-Novoa L., Cacabelos R. Histamine function in brain disorders. Behav. Brain Res. 2001, 124:213-233.
11. Garcia-Falgueras A., Ligtenberg L., Kruijver F.P., Swaab D.F. Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age, and gender identity. J. Comp. Neurol. 2011, 519:3061-3084.
12. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiol. Rev. 2008, 88:1183-1241.
13. Higuchi M., Yanai K., Okamura N., Meguro K., Arai H., Itoh M., Iwata R., Ido T., Watanabe T., Sasaki H. Histamine H(1) receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 2000, 99:721-729.
14. Itowi N., Yamatodani A., Cacabelos R., Goto M., Wada H. Effect of histamine depletion on circadian variations of corticotropin and corticosterone in rats. Neuroendocrinology 1989, 50:187-192.
15. Jin C.Y., Panula P. The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation. Neuroscience 2005, 132:137-149.
16. Jin C.Y., Kalimo H., Panula P. The histaminergic system in human thalamus: correlation of innervation to receptor expression. Eur. J. Neurosci. 2002, 15:1125-1138.
17. Kiviranta T., Tuomisto L., Airaksinen E.M. Diurnal and age-related changes in cerebrospinal fluid tele-methylhistamine levels during infancy and childhood. Pharmacol. Biochem. Behav. 1994, 49:997-1000.
18. Kruijver F.P., Balesar R., Espila A.M., Unmehopa U.A., Swaab D.F. Estrogen-receptor-beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution. J. Comp. Neurol. 2003, 466:251-277.
19. Lin L., Wisor J., Shiba T., Taheri S., Yanai K., Wurts S., Lin X., Vitaterna M., Takahashi J., Lovenberg T.W., Koehl M., Uhl G., Nishino S., Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002, 23:2203-2211.
20. Lin J.S., Sergeeva O.A., Haas H.L. Histamine H3 receptors and sleep-wake regulation. J. Pharmacol. Exp. Ther. 2011, 336:17-23.
21. Liu C.Q., Chen Z., Liu F.X., Hu D.N., Luo J.H. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Neuropharmacology 2007, 53:832-841.
22. Liu C.Q., Hu D.N., Liu F.X., Chen Z., Luo J.H. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist. Pharmacol. Biochem. Behav. 2008, 90:325-330.
23. Liu C.Q., Shan L., Balesar R., Luchetti S., Van Heerikhuize J.J., Luo J.H., Swaab D.F., Bao A.M. A quantitative in situ hybridization protocol for formalin-fixed paraffin-embedded archival post-mortem human brain tissue. Methods 2010, 52:359-366.
24. Medhurst A.D., Roberts J.C., Lee J., Chen C.P., Brown S.H., Roman S., Lai M.K. Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice. Br. J. Pharmacol. 2009, 157:130-138.
25. Motawaj M., Peoc'h K., Callebert J., Arrang J.M. CSF levels of the histamine metabolite tele-methylhistamine are only slightly decreased in Alzheimer's disease. J. Alzheimers Dis. 2011, 22:861-871.
26. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci. Lett. 1993, 151:196-199.
27. Ogawa S., Yanai K., Watanabe T., Wang Z.M., Akaike H., Ito Y., Akaike N. Histamine responses of large neostriatal interneurons in histamine H1 and H2 receptor knock-out mice. Brain Res. Bull. 2009, 78:189-194.
28. Panula P., Rinne J., Kuokkanen K., Eriksson K.S., Sallmen T., Kalimo H., Relja M. Neuronal histamine deficit in Alzheimer's disease. Neuroscience 1998, 82:993-997.
29. Passani M.B., Blandina P. Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol. Sci. 2011, 32:242-249.
30. Prell G.D., Khandelwal J.K., Burns R.S., LeWitt P.A., Green J.P. Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans. Compr. Gerontol. A 1988, 2:114-119.
31. Rinne J.O., Anichtchik O.V., Eriksson K.S., Kaslin J., Tuomisto L., Kalimo H., Roytta M., Panula P. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J. Neurochem. 2002, 81:954-960.
32. Salehi A., Heyn S., Gonatas N.K., Swaab D.F. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neurosci. Lett. 1995, 193:29-32.
33. Sander K., Kottke T., Stark H. Histamine H3 receptor antagonists go to clinics. Biol. Pharm. Bull. 2008, 31:2163-2181.
34. Saper C.B., Chou T.C., Scammell T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001, 24:726-731.
35. Shan L., Bossers K., Luchetti S., Balesar R., Lethbridge N., Chazot P.L., Bao A.M., Swaab D.F. Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study. Neurobiol. Aging 2011, 33(7):1488.e1-1488.e13.
36. Shan L., Liu C.Q., Balesar R., Hofman M.A., Bao A.M., Swaab D.F. Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus. Neurobiol. Aging 2011, 33:1343-1344.
37. Shan L., Hofman M.A., van Wamelen D.J., Van Someren E.J., Bao A.M., Swaab Dick F. Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep 2012, 35:713-715.
38. Shan, L., Bossers, K., Unmehopa, U., Bao, A.M., Swaab, D.F., in press. Alterations in the histaminergic system in Alzheimer's disease: a postmortem study. Neurobiol. Aging. http://dx.doi.org/10.1016/j.neurobiolaging.2011.1012.1026.
39. Trottier S., Chotard C., Traiffort E., Unmehopa U., Fisser B., Swaab D.F., Schwartz J.C. Co-localization of histamine with GABA but not with galanin in the human tuberomamillary nucleus. Brain Res. 2002, 939:52-64.
40. Wu Y.H., Zhou J.N., Balesar R., Unmehopa U., Bao A., Jockers R., Van Heerikhuize J., Swaab D.F. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J. Comp. Neurol. 2006, 499:897-910.
41. Wu G.Y., Han X.H., Zhuang Q.X., Zhang J., Yung W.H., Chan Y.S., Zhu J.N., Wang J.J. Excitatory effect of histamine on rat spinal motoneurons by activation of both H and H receptors in vitro. J. Neurosci. Res. 2012, 90:132-142.
42. Yanai K., Watanabe T., Meguro K., Yokoyama H., Sato I., Sasano H., Itoh M., Iwata R., Takahashi T., Ido T. Age-dependent decrease in histamine H1 receptor in human brains revealed by PET. Neuroreport 1992, 3:433-436.
43. Yanai K., Watanabe T., Yokoyama H., Hatazawa J., Iwata R., Ishiwata K., Meguro K., Itoh M., Takahashi T., Ido T., et al. Mapping of histamine H1 receptors in the human brain using [11C]pyrilamine and positron emission tomography. J. Neurochem. 1992, 59:128-136.
44. Yoshizawa M., Tashiro M., Fukudo S., Yanai K., Utsumi A., Kano M., Karahasi M., Endo Y., Morisita J., Sato Y., Adachi M., Itoh M., Hongo M. Increased brain histamine H1 receptor binding in patients with anorexia nervosa. Biol. Psychiatry 2009, 65:329-335.
45. Zeitzer J.M., Kodama T., Buckmaster C.L., Honda Y., Lyons D.M., Nishino S., Mignot E. Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey. J. Sleep Res. 2011, 21:189-194.